doi: 10.1021/jm00083a023.
Novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles as potential antiallergy agents
Affiliations
- PMID: 1372359
- DOI: 10.1021/jm00083a023
Item in Clipboard
Novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles as potential antiallergy agents
J Med Chem.
.
Abstract
The synthesis and antiallergic activity of a series of novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles are described. A number of the compounds inhibit the release of histamine from anti-IgE stimulated basophils obtained from allergic donors. Optimal inhibition is exhibited in benzothiophenes with a 3-alkoxy substituent in combination with a 5-methoxy, 6-methoxy, or a 5,6-dimethoxy group. Compound 13c (CI-959) also inhibited respiratory burst of human neutrophils and the release of mediators from anti-IgE-stimulated human chopped lung.
Similar articles
-
Novel indolecarboxamidotetrazoles as potential antiallergy agents.J Med Chem. 1989 Jun;32(6):1360-6. doi: 10.1021/jm00126a036. J Med Chem. 1989. PMID: 2470904
-
Novel thiophene-, pyrrole-, furan-, and benzenecarboxamidotetrazoles as potential antiallergy agents.J Med Chem. 1991 Jul;34(7):2186-94. doi: 10.1021/jm00111a039. J Med Chem. 1991. PMID: 1712394
-
Inhibition of histamine, leukotriene C4/D4, and thromboxane B2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI-949.J Allergy Clin Immunol. 1990 Dec;86(6 Pt 1):902-8. doi: 10.1016/s0091-6749(05)80153-8. J Allergy Clin Immunol. 1990. PMID: 1702129
-
CI-959, a new, potential antiallergic drug, inhibits mediator release from lung and contractions of human airways in vitro.Int Arch Allergy Appl Immunol. 1990;93(2-3):267-71. doi: 10.1159/000235312. Int Arch Allergy Appl Immunol. 1990. PMID: 1712004
-
Eosinophils and basophils in allergic airway inflammation.J Allergy Clin Immunol. 1994 Dec;94(6 Pt 2):1250-4. doi: 10.1016/0091-6749(94)90339-5. J Allergy Clin Immunol. 1994. PMID: 7528233 Review. No abstract available.
Cited by
-
Synthesis and Structure-Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase D.ACS Med Chem Lett. 2011 Feb 14;2(2):154-159. doi: 10.1021/ml100230n. ACS Med Chem Lett. 2011. PMID: 21617763 Free PMC article.
-
Total synthesis of (-)-4-desacetoxy-1-oxovindoline: Single atom exchange of an embedded core heteroatom in vindoline.Tetrahedron. 2021 May 7;87:132117. doi: 10.1016/j.tet.2021.132117. Epub 2021 Mar 29. Tetrahedron. 2021. PMID: 33994597 Free PMC article.
-
Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility.BMC Chem Biol. 2010 May 5;10:5. doi: 10.1186/1472-6769-10-5. BMC Chem Biol. 2010. PMID: 20444281 Free PMC article.
-
Classification models and SAR analysis on CysLT1 receptor antagonists using machine learning algorithms.Mol Divers. 2021 Aug;25(3):1597-1616. doi: 10.1007/s11030-020-10165-4. Epub 2021 Feb 3. Mol Divers. 2021. PMID: 33534023
-
Design, Synthesis, and Biological Evaluation of PKD Inhibitors.Pharmaceutics. 2011;3(2):186-228. doi: 10.3390/pharmaceutics3020186. Pharmaceutics. 2011. PMID: 22267986 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Chemical Information
Medical